Primary Site >> Liver Cancer
Gene >> LAPTM4B
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Biological function of a novel gene overexpressed in human hepatocellular carcinoma. PMID: 11775832 |
Ref: Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma. PMID: 12902989 Ref: [Identification and characterization of LAPTM4B encoded by a human hepatocellular carcinoma-associated novel gene]. PMID: 12947545 |
Ref: Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma. PMID: 15162524 |
Ref: Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma. PMID: 15884107 Ref: The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression. PMID: 15911104 Ref: Differential gene expression in pituitary adenomas by oligonucleotide array analysis. PMID: 15994756 |
Ref: Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer. PMID: 17074969 Ref: Overexpression of LAPTM4B-35 closely correlated with clinicopathological features and post-resectional survival of gallbladder carcinoma. PMID: 17276673 |
Ref: Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers. PMID: 17965115 Ref: Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma. PMID: 18334282 |
Ref: LAPTM4B-35, a novel tetratransmembrane protein and its PPRP motif play critical roles in proliferation and metastatic potential of hepatocellular carcinoma cells. PMID: 19843073 |
Ref: LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma. PMID: 19690886 Ref: Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo. PMID: 20202745 Ref: LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma. PMID: 20358632 |
Ref: Highly specific targeting and imaging of live cancer cells by using a peptide probe developed from rationally designed peptides. PMID: 21542089 Ref: Upregulation of LAPTM4B-35 promotes malignant transformation and tumorigenesis in L02 human liver cell line. PMID: 21618708 Ref: Combined lysosomal protein transmembrane 4 beta-35 and argininosuccinate synthetase expression predicts clinical outcome in hepatocellular carcinoma patients. PMID: 21626328 |
Ref: Relationship between LAPTM4B gene polymorphism and susceptibility of primary liver cancer. PMID: 22156622 Ref: Correlation of LAPTM4B polymorphisms with hepatocellular carcinoma in Chinese patients. PMID: 22207410 Ref: LAPTM4B allele *2 is a marker of poor prognosis following hepatic tumor resection for hepatocellular carcinoma. PMID: 22509374 |
Ref: Targeting a novel cancer-driving protein (LAPTM4B-35) by a small molecule (ETS) to inhibit cancer growth and metastasis. PMID: 27542271 |
Ref: Correlation of lysosome-associated protein transmembrane-4beta gene overexpression with the malignant phenotypes of hepatocellular carcinoma. PMID: 29108920 Ref: Long Noncoding RNA HCAL Facilitates the Growth and Metastasis of Hepatocellular Carcinoma by Acting as a ceRNA of LAPTM4B. PMID: 29246322 |
Ref: AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity. PMID: 29337428 Ref: Expression signature of lysosomal-associated transmembrane protein 4B in hepatitis C virus-induced hepatocellular carcinoma. PMID: 29882487 |